Sorafenib-induced eruptive melanocytic lesions

MeSH terms

• Administration, Oral
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects*
• Benzenesulfonates / administration & dosage
• Benzenesulfonates / adverse effects*
• Biopsy
• Carcinoma, Renal Cell / drug therapy
• Carcinoma, Renal Cell / secondary
• Diagnosis, Differential
• Drug Eruptions / etiology*
• Drug Eruptions / pathology
• Female
• Follow-Up Studies
• Humans
• Kidney Neoplasms / drug therapy
• Kidney Neoplasms / pathology
• Male
• Middle Aged
• Nevus, Pigmented / chemically induced*
• Nevus, Pigmented / pathology
• Niacinamide / analogs & derivatives
• Phenylurea Compounds
• Pyridines / administration & dosage
• Pyridines / adverse effects*
• Receptors, Vascular Endothelial Growth Factor
• Skin / pathology
• Skin Neoplasms / chemically induced*
• Skin Neoplasms / pathology
• Sorafenib